Expertise: Phase IV studies and registries, mental health, gene therapy, diabetes, gastrointestinal disorders, epilepsy, and allergic disorders

Ms. Schrammel offers more than 14 years professional experience, including senior-level positions in the late phase divisions of major CROs. At PharmaNet, Ms. Schrammel develops strategic program plans and tactical execution plans for Phase IV studies and registries. As Vice President, Strategy and Development for the late phase division of an international CRO, she directed all business development and marketing initiatives and led the division's North American accelerated launch. During her career, Ms. Schrammel has designed and managed late phase programs including patient registries, clinical-experience trials, pharmacoeconomic trials, and managed-care-based effectiveness trials.

Ms. Schrammel is an author or co-author of numerous articles appearing in pharmaceutical journals and has delivered many presentations at industry conferences.